Markets at a Glance: FIIs Back, Earnings in Focus, Asia Leads Global Rally, Corporate India Stays in High Gear

Today's Market at 08:30am
US Market (Futures)
      Nasdaq = +24.70
      Dow Jones = +17.40
      S&P 500 = +5.90
European (Futures)
      Ftse 100 = +11.70
      Cac 40 = +6.70
      Dax = +32.00
Asian
      Nikkei 225 = +530.87
      ASX 200 = +37.90
      Straits Times = +25.71
      Hang Seng = -44.92
      KOSPI = -0.86
      Taiwan weighted = ,+256.06
      Shanghai (SSE) = +15.80
Gift Nifty = 23979.50 (-209.50)

FII and DII Trading Activity May 8, 2025 in Cash market:
FIIs: Net Buy of ₹2,007.96 crore
DIIs: Net Sell of ₹596.25 crore

 Results Today 
Dr Reddy's Laboratories, ABB India, Swiggy, Bank of India, Manappuram Finance, Birla Corporation, Cera Sanitaryware, Cholamandalam Financial Holdings, Great Eastern Shipping Company, India Shelter Finance Corporation, Jupiter Life Line Hospitals, CE Info Systems, Motherson Sumi Wiring India, Navin Fluorine International, Novartis India, PTC India Financial Services, and Thermax will release their quarterly earnings on May 9.

Results on May 10
Apollo Pipes, Atul Auto, Borosil Renewables, Mangalam Cement, Meghmani Organics, Seshasayee Paper and Boards, and Triveni Turbine will announce their quarterly earnings on May 10.

Post Market Earnings Announcements

Larsen & Toubro Q4 (Consolidated YoY)
- Profit jumps 25% to Rs 5,497 crore Vs Rs 4,396 crore
- Revenue increases 11% to Rs 74,392 crore Vs Rs 67,078 crore
- EBITDA grows 13% to Rs 8,203 crore Vs Rs 7,234 crore
- Margin expands to 11% Vs 10.8%
- Board recommends final dividend of Rs 34 per share
L&T FY26 Guidance
- Revenue growth seen at 15%
- Core margins guidance seen at 8.5% Vs 8.3% in FY25
- Order inflow growth seen at 10%
Britannia Industries Q4 (Consolidated YoY)
- Profit rises 4.2% to Rs 559.1 crore Vs Rs 536.6 crore
- Revenue grows 8.9% to Rs 4,432.2 crore Vs Rs 4,069.4
- Board recommends final dividend of Rs 75 per share
Titan Company Q4 (Standalone YoY)
- Profit soars 10.7% to Rs 870 crore Vs Rs 786 crore
- Revenue increases 19.7% to Rs 13,477 crore Vs Rs 11,257 crore
- EBITDA spikes 29.7% to Rs 1,438 crore Vs Rs 1,109 crore
- Margin expands to 10.7% Vs 9.9%
- Board recommends dividend of Rs 11 per share
Union Bank of India Q4 (Standalone YoY)
- Profit zooms 50.6% to Rs 4,984.9 crore Vs Rs 3,310.6 crore
- Net interest income rises 0.8% to Rs 9,514 crore Vs Rs 9,436.6 crore
- Provisions and contingencies jump to Rs 1,543.9 crore Vs Rs 1,259.6 crore
- Gross NPA drops to 3.60% Vs 3.85% (QoQ)
- Net NPA declines to 0.63% Vs 0.82% (QoQ)
Dilip Buildcon Q4 (Consolidated YoY)
- Profit spikes 32-fold to Rs 170.8 crore Vs Rs 5.3 crore
- Revenue drops 8% to Rs 3,096.1 crore Vs Rs 3,365.6 crore
- Exceptional gain of Rs 36 crore Vs Rs 98.6 crore
MCX India Q4 (Consolidated YoY)
- Profit soars 54.2% to Rs 135.5 crore Vs Rs 87.9 crore
- Revenue jumps 60.8% to Rs 291.3 crore Vs Rs 181.1 crore
- Board recommends final dividend of Rs 30 per share
Biocon Q4 (Consolidated YoY)
- Profit grows 154.2% to Rs 344.5 crore Vs Rs 135.5 crore
- Revenue increases 12.8% to Rs 4,417 crore Vs Rs 3,917.1 crore
IIFL Finance Q4 (Standalone YoY)
- Profit tanks 76.7% to Rs 38.4 crore Vs Rs 165 crore
- Net interest income falls 40.1% to Rs 546.7 crore Vs Rs 913 crore
Pidilite Industries Q4 (Consolidated YoY)
- Profit jumps 40.5% to Rs 427.5 crore Vs Rs 304.3 crore
- Revenue grows 8.2% to Rs 3,141.1 crore Vs Rs 2,901.9 crore
- Board recommends dividend of Rs 20 per share
Chambal Fertilisers and Chemicals Q4 (Consolidated YoY)
- Profit zooms 34.7% to Rs 130.4 crore Vs Rs 96.8 crore
- Revenue falls 7.4% to Rs 2,448.7 crore Vs Rs 2,643 crore
- Board recommends final dividend of Rs 5 per share
Zee Entertainment Enterprises Q4 (Consolidated YoY)
- Profit zooms more than 15-fold to Rs 188.6 crore Vs Rs 12.2 crore
- Revenue rises 0.65% to Rs 2,184.1 crore Vs Rs 2,170 crore
Jindal Stainless Q4 (Consolidated YoY)
- Profit soars 17.8% to Rs 590 crore Vs Rs 500.7 crore
- Revenue increases 7.9% to Rs 10,198.3 crore Vs Rs 9,454 crore
 REC Q4 (Standalone YoY) 
- Profit rises 5.5% to Rs 4,236.2 crore Vs Rs 4,016.3 crore
- Total income grows 20% to Rs 15,174.2 crore Vs Rs 12,643.3 crore
 Kalyan Jewellers Q4 (Consolidated YoY) 
- Profit jumps 36.3% to Rs 187.6 crore Vs Rs 137.6 crore
- Revenue grows 36.6% to Rs 61,815.3 crore Vs Rs 45,250.1 crore

Key Corporate Developments and Updates

 Venus Pipes & Tubes: Received a Rs 190 crore Letter of Intent from a leading Indian power equipment manufacturer for stainless steel seamless boiler tubes for Supercritical and Subcritical Thermal Power Projects.
 Lupin: Gained US FDA approval for its Raltegravir tablets USP, 600 mg, bioequivalent to Isentress HD by Merck. As the exclusive first-to-file, Lupin gets 180 days of generic exclusivity. The drug treats HIV-1 in combination with other antiretrovirals.
 Bharat Petroleum Corporation: Awarded contracts for 100 MW windfarm projects—50 MW each in Madhya Pradesh (to Suzlon Energy) and Maharashtra (to Integrum Energy). Completion expected within two years.
 Mahindra & Mahindra Financial Services: Board approved a Rs 2,996.16 crore rights issue for 15.44 crore shares at Rs 194 per share; eligible shareholders get 1 rights share for every 8 held.
 Brigade Enterprises: Acquired 11-acre land in Whitefield, Bengaluru, to develop a premium commercial project with 1.5 million sq. ft. leasable area and a development value of over Rs 2,000 crore.
 One97 Communications (Paytm): Settled with SEBI over ESOP-related issues. Vijay and Ajay Sharma paid Rs 2.8 crore and had their ESOPs (2.1 crore for Vijay, 2.23 lakh for Ajay) canceled. Vijay is barred from accepting new ESOPs from listed companies for 3 years.
 Tata Motors: NCLT approved the merger of Tata Motors Finance with Tata Motors, ending its status as a step-down subsidiary.
 ONGC: Clarified that its technical service contract with BP for the Mumbai High field remains active, despite reports of tender-related uncertainties.
 Gensol Engineering: SEBI appointed a forensic accountant and investigator for a forensic audit of its financials for FY 2022–2025.
 Birla Corp: Approved capex for expanding capacity, including a 3.70 MTPA plant in Madhya Pradesh and two Greenfield Grinding Units in Uttar Pradesh totaling 3.40 MTPA.
 Zydus Lifesciences: Received final US FDA approval for Glatiramer Acetate Injection to treat relapsing forms of multiple sclerosis.
 Reliance Industries: Announced voluntary dissolution of its step-down subsidiary, skyTran Inc.

 SME Listing on May 9 
Kenrik Industries
 Stock Trades Ex-Date for Rights 
Sattva Sukun Lifecare
 Stocks Trade Ex-Date for Split 
Navkar Urbanstructure, Shantai Industries
 Stocks Trade Ex-Dividend 
Bajaj Finance, Anand Rathi Wealth, Coforge, Laurus Labs, Bank of Maharashtra, Transformers and Rectifiers (India), UCO Bank
 Stock Trades Ex-Date for Income Distribution (InvIT) 
Indus Infra Trust
 Stocks Trade Ex-Date for Spin Off 
Chembond Chemicals, CP Capital
 Stocks in F&O ban 
Central Depository Services, Manappuram Finance, RBL Bank

Source: Moneycontrol, NDTVPROFIT, NSE India, Investing.com

 

STORIES YOU MAY LIKE

Dr. Reddy's Powers Ahead: G V Prasad Reappointed, Dividend Announced, and Q4 Beats Estimates

Profit on the Horizon? Inside Swiggy Instamart’s High-Speed Turnaround Plan

Bank of India Reports Strong Q4: Net Profit Jumps, Asset Quality Enhances, Dividend Declared